(170) Kawamura A, Matsuda K, Murakami Y, Saruta M, Kohno T, Shiraishi K. Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma. Sci Rep. 2023 Aug 9;13(1):12944.
(169) Shi J et al. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 2023 May 26;14(1):3043.
(168) Shida D, Kuchiba A, Shibata T, Hamaguchi T, Yamasaki S, Ito M, Kobatake
T, Tonooka T, Masaki T, Shiozawa M, Takii Y, Uetake H, Okamura S, Ojima
H, Kazama S, Takeyama H, Kanato K, Shimada Y, Murakami Y, Kanemitsu Y.
Genomic landscape and its prognostic significance in stage III colorectal
cancer: JCOG1506A1, an ancillary of JCOG0910. Cancer Sci. 2023 Aug;114(8):3352-3363.
(167) Usui Y, Taniyama Y, Endo M, Koyanagi YN, Kasugai Y, Oze I, Ito H,
Imoto I, Tanaka T, Tajika M, Niwa Y, Iwasaki Y, Aoi T, Hakozaki N, Takata
S, Suzuki K, Terao C, Hatakeyama M, Hirata M, Sugano K, Yoshida T, Kamatani
Y, Nakagawa H, Matsuda K, Murakami Y, Spurdle AB, Matsuo K, Momozawa Y.
Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. N Engl J Med. 2023 Mar 30;388(13):1181-1190.
(166) Wang Y, Namba S, Lopera E, Kerminen S, Tsuo K, Lall K, Kanai M, Zhou W, Wu KH, Fave MJ, Bhatta L, Awadalla P, Brumpton B, Deelen P, Hveem K, Lo Faro V, Magi R, Murakami Y, Sanna S, Smoller JW, Uzunovic J, Wolford BN; Global Biobank Meta-analysis Initiative; Willer C, Gamazon ER, Cox NJ, Surakka I, Okada Y, Martin AR, Hirbo J. Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts. Cell Genom. 2023 Jan 4;3(1):100241.
(165) Akiyama M, Sakaue S, Takahashi A, Ishigaki K, Hirata M, Matsuda K, Momozawa Y, Okada Y, Ninomiya T; Biobank Japan project; Terao C, Murakami Y, Kubo M, Kamatani Y. Genome-wide association study reveals BET1L associated with survival time in the 137,693 Japanese individuals. Commun Biol. 2023 Feb 3;6(1):143.
(164) Miyazawa K, Ito K, Ito M, Zou Z, Kubota M, Nomura S, Matsunaga H, Koyama S, Ieki H, Akiyama M, Koike Y, Kurosawa R, Yoshida H, Ozaki K, Onouchi Y; BioBank Japan Project; Takahashi A, Matsuda K, Murakami Y, Aburatani H, Kubo M, Momozawa Y, Terao C, Oki S, Akazawa H, Kamatani Y, Komuro I. Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nat Genet. 2023 Feb;55(2):187-197.
(163) Tomofuji Y, Suzuki K, Kishikawa T, Shojima N, Hosoe J, Inagaki K, Matsubayashi S, Ishihara H, Watada H, Ishigaki Y; BioBank Japan Project; Inohara H, Murakami Y, Matsuda K, Okada Y, Yamauchi T, Kadowaki T. Identification of serum metabolome signatures associated with retinal and renal complications of type 2 diabetes. Commun Med (Lond). 2023 Jan 9;3(1):5.
(162) Kanoni S et al. Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis. Genome Biol. 2022 Dec 27;23(1):268.
(161) Okawa Y, Iwasaki Y, Johnson TA, Ebata N, Inai C, Endo M, Maejima K, Sasagawa S, Fujita M, Matsuda K, Murakami Y, Nakamura T, Hirano S, Momozawa Y, Nakagawa H. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer. J Hepatol. 2023 Feb;78(2):333-342.
(160) Sekine Y, Iwasaki Y, Hakozaki N, Endo M, Kamatani Y, Matsuda K, Murakami Y, Sano T, Akamatsu S, Kobayashi T, Nakagawa H, Numakura K, Narita S, Habuchi T, Momozawa Y. Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese. Jpn J Clin Oncol. 2022 Dec 5;52(12):1441-1445.
(159) Usui Y, Iwasaki Y, Matsuo K, Endo M, Kamatani Y, Hirata M, Sugano
K, Yoshida T, Matsuda K, Murakami Y, Maeda Y, Nakagawa H, Momozawa Y. Association
between germline pathogenic variants in cancer-predisposing genes and lymphoma
risk. Cancer Sci. 2022 Nov;113(11):3972-3979.
(158) Ramdas S et al. A multi-layer functional genomic analysis to understand
noncoding genetic variation in lipids. Am J Hum Genet. 2022 Aug 4;109(8):1366-1387.
(157) Sekine Y, Iwasaki Y, Aoi T, Endo M, Hirata M, Kamatani Y, Matsuda K, Sugano K, Yoshida T, Murakami Y, Fukui T, Akamatsu S, Ogawa O, Nakagawa H, Numakura K, Narita S, Habuchi T, Momozawa Y. Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls. Hum Mol Genet. 2022 Jun 22;31(12):1962-1969.
(156) Kanemoto Y, Nishimura K, Hayakawa A, Sawada T, Amano R, Mori J, Kurokawa T, Murakami Y, Kato S. A long non-coding RNA as a direct vitamin D target transcribed from the antisense strand of the human HSD17B2 locus. Biosci Rep. 2022 May 27;42(5):BSR20220321.
(155) Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y,
Parsons MT, Mizukami K, Sekine Y, Hirata M, Kamatani Y, Endo M, Inai C,
Takata S, Ito H, Kohno T, Matsuda K, Nakamura S, Sugano K, Yoshida T, Nakagawa
H, Matsuo K, Murakami Y, Spurdle AB, Kubo M. Expansion of Cancer Risk Profile
for BRCA1 and BRCA2 Pathogenic Variants. JAMA Oncol. 2022 Jun 1;8(6):871-878.
(154) Murakami Y. [Cohorts and Biobanks as Essential Resources for Cancer
Research]. Gan To Kagaku Ryoho. 2022 Feb;49(2):129-132.
(153) Kawai H, Matsuoka R, Ito T, Matsubara D. Molecular subtypes of high-grade
neuroendocrine carcinoma (HGNEC): What is YAP1-positive HGNEC? Front Biosci (Landmark Ed). 27: 108, 2022.
(152) Kasai Y, Gan SP, Funaki T, Ohashi-Kumagai Y, Tominaga M, Shiu SJ,
Suzuki D, Matsubara D, Sakamoto T, Sakurai-Yageta M, Ito T, Murakami Y.
Trans-homophilic interaction of CADM1 promotes organ infiltration of T-cell
lymphoma by adhesion to vascular endothelium. Cancer Sci. 113: 1669-1678, 2022.
(151) Akashi K, Sakai T, Fukuoka O, Saito Y, Yoshida M, Ando M, Ito T,
Murakami Y, Yamasoba T. Usefulness of circulating tumor DNA by targeting
human papilloma virus-derived sequences as a biomarker in p16-positive
oropharyngeal cancer. Sci Rep. 12: 572, 2022.
2019 - 2021
(150) Graham SE et al, The power of genetic diversity in genome-wide association
studies of lipids. Nature. 600: 675-679, 2021
(149) Hikino K et al, Genome-wide association study of colorectal polyps
identified highly overlapping polygenic architecture with colorectal cancer.
J Hum Genet. 67: 149-156, 2021.
(148) Sakamoto T, Fukui Y, Kondoh Y, Honda K, Shimizu T, Hara T, Hayashi
T, Saitoh Y, Murakami Y, Inoue JI, Kaneko S, Osada H, Seiki M. Pharmacological
inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic
shock. Commun Biol. 4: 1165, 2021.
(147) Sakaue S et al, A cross-population atlas of genetic associations
for 220 human phenotypes. Nat Genet. 53: 1415-1424, 2021.
(146) Sato A, Tanabe M, Tsuboi Y, Niwa T, Shinozaki-Ushiku A, Seto Y, Murakami
Y. Circulating Tumor DNA Harboring the BRAF V600E Mutation May Predict Poor Outcomes of Primary Papillary Thyroid Cancer
Patients. Thyroid. 31: 1822-1828, 2021.
(145) Hikino K et al, Susceptibility loci and polygenic architecture highlight
population specific and common genetic features in inguinal hernias: genetics
in inguinal hernias. EBioMedicine. 70: 103532, 2021.
(144) Muramatsu M, Ito T, Shimoji H, Komiya M, Miyamura Y, Nishiyama K,
Suzuki T, Minami T. NFAT indicates nucleocytoplasmic damped oscillation
via its feedback modulator .Biochem Biophys Res Commun. 571: 201-209, 2021.
(143) Saiki R et al, Combined landscape of single-nucleotide variants and
copy number alterations in clonal hematopoiesis. Nat Med. 27: 1239-1249, 2021.
(142) Zekavat SM et al, Hematopoietic mosaic chromosomal alterations increase
the risk for diverse types of infection. Nat Med. 27: 1012-1024, 2021.
(141) Wang QS et al, Leveraging supervised learning for functionally informed
fine-mapping of cis-eQTLs identifies an additional 20,913 putative causal
eQTLs. Nat Commun. 12: 3394, 2021
(140) Gharahkhani P et al, Genome-wide meta-analysis identifies 127 open-angle
glaucoma loci with consistent effect across ancestries. Nat Commun. 12: 1258, 2021.
(139) Chung Y, Saitoh Y, Hayashi T, Fukui Y, Terada N, Seiki M, Murakami
Y, Sakamoto T. Mint3 is dispensable for pancreatic and kidney functions
in mice. Biochem Biophys Rep. 24: 100872, 2020.
(138) Fujita M et al, Population-based screening for hereditary colorectal
cancer variants in Japan. Clin Gastroenterol Hepatol. 2020 in press.
(137) Funaki T, Ito T, Tanei ZI, Goto A, Niki T, Matsubara D, Murakami Y. CADM1 promotes malignant features of small-cell lung cancer by recruiting 4.1R to the plasma membrane. Biochem Biophys Res Commun. 534: 172-178, 2021.
(136) Amariuta T, Ishigaki K, Sugishita H, Ohta T, Koido M, Dey KK, Matsuda
K, Murakami Y, Price AL, Kawakami E, Terao C, Raychaudhuri S. Improving
the trans-ancestry portability of polygenic risk scores by prioritizing
variants in predicted cell-type-specific regulatory elements. Nat Genet. 52: 1346-1354, 2020.
(135) Masuda T, Ito H, Hirata J, Sakaue S, Ueda Y, Kimura T, Takeuchi F,
Murakami Y, Matsuda K, Matso K, Okada Y. Fine Mapping of the Major Histocompatibility
Complex Region and Association of the HLA-B*52:01 Allele With Cervical
Cancer in Japanese Women. JAMA Netw Open, 3: e2023248, 2020.
(134) Koyama S et al, Population-specific and trans-ancestry genome-wide
analyses identify distinct and shared genetic risk loci for coronary artery
disease. Nat Genet, 52: 1169-1177, 2020.
(133) Masuda T, Ogawa K, Kamatani Y, Murakami Y, Kimura T, Okada Y. A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese. Cancer Sci. 111: 4646-4651, 2020.
(132) Mizukami K, Iwasaki Y, Kawakami E, Hirata M, Kamatani Y, Matsuda
K, Endo M, Sugano K, Yoshida T, Murakami Y, Nakagawa H, Spurdle AB, Momozawa
Y. Genetic characterization of pancreatic cancer patients and prediction
of carrier status of germline pathogenic variants in cancer-predisposing
genes. EBioMedicine. 60: 103033, 2020.
(131) Vuckovic D et al, The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell. 182: 1214-1231, 2020.
(130) Chen MH et al, Trans-ethnic and Ancestry-Specific Blood-Cell Genetics
in 746,667 Individuals from 5 Global Populations. Cell. 182: 1198-1213, 2020.
(129) Murakami F, Tsuboi Y, Takahashi Y, Horimoto Y, Mogushi K, Ito T,
Emi M, Matsubara D, Shibata T, Saito M, Murakami Y. Short somatic alterations
at the site of copy number variation in breast cancer. Cancer Sci. 112: 444-453, 2020.
(128) Kanamori A, Matsubara D, Saitoh Y, Fukui Y, Gotoh N, Kaneko S, Seiki
M, Murakami Y, Inoue JI, Sakamoto T. Mint3 depletion restricts tumor malignancy
of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. Oncogene. 39: 6218-6230, 2020.
(127) Liu X, Kosugi S, Koide R, Kawamura Y, Ito J, Miura H, Matoba N, Matsuzaki
M, Fujita M, Kamada AJ, Nakagawa H, Tamiya G, Matsuda K,Murakami Y, Kubo M, Aswad A, Sato K, Momozawa Y, Ohashi J, Terao C, Yoshikawa
T, Parrish NF, Kamatani Y. Endogenization and excision of human herpesvirus
6 in human genomes. PLoS Genet. 16: e1008915, 2020.
(126) Tsuboi Y, Oyama M, Kozuka-Hata H, Ito A, Matsubara D,Murakami Y. CADM1 suppresses c-Src activation by binding with Cbp on membrane
lipid rafts and intervenes colon carcinogenesis. Biochem Biophys Res Commun. 529: 854-860, 2020.
(125) Terao C, Suzuki A, Momozawa Y, Akiyama M, Ishigaki K, Yamamoto K,
Matsuda K,Murakami Y, McCarroll SA, Kubo M, Loh PR, Kamatani Y. Chromosomal alterations among age-related haematopoietic clones in Japan. Nature. 584: 130-135, 2020.
(124) Lin Y et al, Genome-wide association meta-analysis identifies GP2
gene risk variants for pancreatic cancer. Nat Commun. 11: 3175, 2020.
(123) Yoshino S, Matsui Y, Fukui Y, Seki M, Yamaguchi K, Kanamori A, Saitoh
Y, Shimamura T, Suzuki Y, Furukawa Y, Kaneko S, Seiki M,Murakami Y, Inoue JI, Sakamoto T. EXOSC9 depletion attenuates P-body formation,
stress resistance, and tumorigenicity of cancer cells. Sci Rep. 10: 9275, 2020.
(122) Ishigaki K et al, Large-scale genome-wide association study in a
Japanese population identifies novel susceptibility loci across different
diseases. Nat Genet. 52: 669-679, 2020.
(121) Matsunaga H et al, Transethnic Meta-Analysis of Genome-Wide Association
Studies Identifies Three New Loci and Characterizes Population-Specific
Differences for Coronary Artery Disease. Circ Genom Precis Med. 13: e002670, 2020.
(120) Sakaue S, Kanai M, Karjalainen J, Akiyama M, Kurki M, Matoba N, Takahashi
A, Hirata M, Kubo M, Matsuda K, Murakami, FinnGen, Daly MJ, Kamatani Y,
Okada Y. Trans-biobank analysis with 676,000 individuals elucidates the
association of polygenic risk scores of complex traits with human lifespan.
Nat Med. 26: 542-548, 2020.
(119) Matsubara D, Yoshimot T, Soda M, Amano Y, Kihara A, Funaki T, Ito T, Sakuma Y, Shibano T, Endo S, Hagiwara K, Ishikawa S, Fukayama M, Murakami Y, Mano H, Niki T. Reciprocal expression of Trefoil factor-1 and Thyroid transcription factor-1 in lung adenocarcinomas. Cancer Sci. 111: 2183-2195, 2020.
(118) Sakaue S, Hirata J, Kanai M, Suzuki K, Akiyama M, Too CL, Arayssi T, Hammoudeh M, Emadi SA, Masri BK, Halabi H, Badsha H, Uthman IW, Saxena R, Padyukov L, Hirata M, Matsuda K, Murakami Y, Kamatani Y, Okada Y. Dimensionality reduction reveals fine-scale structure in the Japanese population with consequences for polygenic risk prediction. Nat Commun. 11: 1569, 2020.
(117) Yamamoto K, Sakaue S, Matsuda K, Murakami Y, Kamatani Y, Ozono K, Momozawa Y, Okada Y. Genetic and phenotypic landscape of the mitochondrial genome in the Japanese population. Commun Biol. 3: 104, 2020.
(116) Matoba N, Akiyama M, Ishigaki K, Kanai M, Takahashi A, Momozawa Y,
Ikegawa S, Ikeda M, Iwata N, Hirata M, Matsuda K, Murakami Y, Kubo M, Kamatani
Y, Okada Y. GWAS of 165,084 Japanese individuals identified nine loci associated
with dietary habits. Nat Hum Behav. 4: 308-316, 2020.
(115) Yasumizu Y, Sakaue S, Konuma T, Suzuki K, Matsuda K, Murakami Y,
Kubo M, Palamara PF, Kamatani Y, Okada Y. Genome-wide natural selection
signatures are linked to genetic risk of modern phynotypes in the Japanese
population. Mol Biol Evol. 37: 1306-1316, 2020.
(114) Low SK, Chin YM, Ito H, Matsuo K, Tanikawa C, Matsuda K, Saito H,
Sakurai-Yageta M, Nakaya N, Shimizu A, Nishizuka SS, Yamaji T, Sawada N,
Iwasaki M, Tsugane S, Takezaki T, Suzuki S, Naito M, Wakai K, Kamatani
Y, Momozawa Y, Murakami Y, Inazawa J, Nakamura Y, Kubo M, Katagiri T, Miki
Y. Identification of two novel breast cancer loci through large-scale genome-wide
association study in the Japanese population. Sci Rep. 9: 17332, 2019.
(113) Thompson DJ et al. Genetic predisposition to mosaic Y chromosome
loss in blood. Nature. 575: 652-657.
(112) Clark DW et al. Associations of autozygosity with a broad range of
human phenotypes. Nat Commun. 10: 4957, 2019.
(111) Hikino K, Ozeki T, Koido M, Terao C, Kamatani Y, Mizusawa Y, Shiohara
T, Tohyama M, Azukizawa H, Aihara M, Nihara H, Morita E, Murakami Y, Kubo
M, Mushiroda T. HLA-B*51:01 and CYP2C9*3 are risk factors for Phenytoin-induced
eruption in the Japanese population: analysis of data from the Biobank
Japan project. Clin Pharmacol Ther. 107: 1170-1178, 2020.
(110) Terao C, Momozawa Y, Ishigaki K, Kawakami E, Akiyama M, Loh PR, Genovese
G, Sugishita H, Ohta T, Hirata M, Perry JRB, Matsuda K, Murakami Y, Kubo
M, KAmatani Y. GWAS of mosaic loss of chromosome Y highlights genetic effects
on blood cell differentiation. Nat Commun. 10: 4719, 2019.
(109) Hikino K, Ozeki T, Koido M, Terao C, Kamatani Y, Murakami Y, Kubo M, Mushiroda T. Comparison of effects of UGT1A1*6 and UGT1A1*28 on Irinotecan-induced adverse reactions in the Japanese population: analysis of the Biobank Japan project. J Hum Genet. 64: 1195-1202, 2019.
(108) Akiyama M, Ishigaki K, Sakaue S, Momozawa Y, Horikoshi M, Hirata
M, Matsuda K, Ikegawa S, Takahashi A, Kanai M, Suzuki S, Matsui D, Naito
M, Yamaji T, Iwasaki M, Sawada N, Tanno K, Sasaki M, Hozawa A, Minegishi
N, Wakai K, Tsugane S, Shimizu A, Yamamoto M, Okada Y, Murakami Y, Kubo
M, Kamatani Y. Characterizing rare and low-frequency height-associated
variants in the Japanese population. Nat Commun. 10: 4393, 2019.
(107) Sakaue S, Akiyama M, Hirata M, Matsuda K, Murakami Y, Kubo M, Kamatani
Y, Okada Y. Functional variants in ADH1B and ALDH2 are non-additively associated
with all-cause mortality in Japanese population. Eur J Hum Genet. 28: 378-382, 2020.
(106) Matsuda T, Low SK, Akiyama M, Hirata M, Ueda Y, Matsuda K, Kimura T, Murakami Y, Kubo M, Kamatani Y, Okada Y. GWAS of five gynecologic diseases and cross-trait analysis in Japanese. Eur J Hum Genet. 28: 95-107, 2020.
(105) Momozawa Y, Iwasaki Y, Hirata M, Liu X, Kamatani Y, Takahashi A,
Sugano K, Yoshida T, Murakami Y, Matsuda K, Nakagawa H, Spurdle A, Kubo
M. Germline pathologic variants in 7636 Japanese patients with prostate
cancer and 12366 controls. J Natl Cancer Inst. 112: 369-376, 2020.
(104) Ito T, Nakamura A, Tanaka I, Tsuboi Y, Morikawa T, Nakajima J, Takai D, Fukayama M, Sekido Y, Niki T, Matsubara D, Murakami Y. CADM1 associates with Hippo pathway core kinases; membranous coexpression of CADM1 and LATS2 in lung tumors predicts good prognosis. Cancer Sci. 110: 2284-2295, 2019.
(103) Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ishihara
S, Akiyama M, Ikezaki H, Frusyo N, Shimizu S, Yamamoto K, Hirata M, Okada
R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T,
Nakajima M, Takao M, Ozaki E, MAtsui D, Nishiyama T, Suzuki S, Takashima
N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura
Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami
Y, Matsubata T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai
K, Okada Y, Matsuo H. Genome-wide meta-analysis identifies multiple novel
loci associated with serum uric acid levels in Japanese individuals. Commun Biol. 2: 115, 2019.
(102) Tanikawa C, Kamatani Y, Terao C, Usami M, Takahashi A, Momozawa Y,
Suzuki K, Ogishima S, Shimizu A, Satoh M, Matsuo K, Mikami H, Naito M,
Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Kohri K, Yu ASL, Yasui
T, Murakami Y, Kubo M, Matsuda K. Novel risk loci identified in a genome-wide
association study of urolithiasis in a Japanese population. J Am Soc Nephrol. 30: 855-864, 2019.
(101) Ito T, Kumagai Y, Itano K, Maruyama T, Tamura K, Kawasaki S, Suzuki
T, Murakami Y. Mathematical analysis of gefitinib resistance of lung adenocarcinoma
caused by MET amplification. Biochem Biophys Res Commun. 511: 544-550, 2019.
(100) Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, Hozawa
A, Kadota A, Kuriki K, Naito M, Tanno K, Ishigaki Y, Hirata M, Matsuda
K, Iwata N, Ikeda M, Sawada N, Yamaji T, Iwasaki M, Ikegawa S, Maeda S,
Murakami Y, Wakai K, Tsugane S, Sasaki M, Yamamoto M, Okada Y, Kubo M,
Kamatani Y, Horikoshi M, Yamauchi T, Kadowaki T. Identification of 28 new
susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet. 51: 379-386, 2019.
(99) Kanke Y, Saito M, Abe N, Saito K, Goto A, Ohtake T, Murakami Y, Kono
K. Expression profile of CADM1 and CADM4 in triple negative breast cancer
with primary systemic therapy.Oncol Lett. 17: 921-926, 2019.
2016 - 2018
(98) Yodsurang V, Tang Y, Takahashi Y, Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Fuse N, Sugawara J, Shimizu A, Fukushima A, Hishida A, Furusyo N, Naito M, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Hirata M, Murakami Y, Kubo M, Matsuda K. Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1. PLoS One. 13: e0209096, 2018.
(97) Tanikawa C, Kamatani Y, Toyoshima O, Sakamoto H, Ito H, Takahashi
A, Momozawa Y, Hirata M, Fuse N, Takai-Igarashi T, Shimizu A, Sasaki M,
Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Hishida A, Wakai K,
Furusyo N, Murakami Y, Nakamura Y, Imoto I, Inazawa J, Oze I, Sato N, Tanioka
F, Sugimura H, Hirose H, Yoshida T, Matsuo K, Kubo M, Matsuda K. Genome-wide
association study identifies gastric cancer susceptibility loci at 12q24.11-12
and 20q11.21. Cancer Sci. 109: 4015-4024, 2018.
(96) Ito T, Kasai Y, Kumagai Y, Suzuki D, Ochiai-Noguchi M, Irikura D, Miyake S, Murakami Y. Quantitative analysis of interaction between CADM1 and its binding cell-surface proteins using surface plasmon resonance imaging. Front Cell Dev Biol. 6: 86, 2018.
(95) Kabe Y, Suematsu M, Sakamoto S, Hirai M, Koike I, Hishiki T, Matsuda A, Hasegawa Y, Tsujita K, Ono M, Minegishi N, Hozawa A, Murakami Y, Kubo M, Itonaga M, Handa H. Development of a highly sensitive device for counting the number of disease-specific exosomes in human sera. Clin Chem. 64: 1463-1473, 2018.
(94) Ri A, Hagiyama M, Inoue T, Yoneshige A, Kimura R, Murakami Y, Ito
A. Progression of plumonary emphysema and continued increase in ectodomain
shedding of cell adhesion molecule 1 after cessation of cigarette smoke
exposure in mice. Front Cell Dev Biol. 6: 52, 2018.
(93) Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Leveque K, Nagayama
S, Mimori K, Mori M, Ishii H, Inazawa J, Yasuda J, Tsuboi A, Shimizu A,
Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Wakai K, Koyama
T, Takezaki T, Yuji K, Murakami Y, Nakamura Y, Kubo M, Matsuda K. GWAS
Identifies Two Novel Colorectal Cancer Loci at 16q24.1 and 20q13.12. Carcinogenesis. 39: 652-660, 2018.
(92) Saito M, Goto A, Abe N, Saito K, Maeda D, Ohtake T, Murakami Y, Takenoshita
S. Decreased expression of CADM1 and CADM4 are associated with advanced
stage breast cancer. Oncol Lett. 15: 2401-2406, 2018.
(91) Daigo K, Takano A, Thang PM, Yoshitake Y, Shinohara M, Tohnai I, Murakami
Y, Maegawa J, Daigo Y. Characterization of KIF11 as a novel prognostic
biomarker and therapeutic target for oral cancer. Int J Oncol. 52: 155-165, 2018.
(90) Hara T, Murakami Y, Seiki M, Sakamoto T. Mint3 in bone marrow-derived
cells promotes lung metastasis in breast cancer model mice. Biochem Biophys Res Commun. 490: 688-692, 2017.
(89) Sakamoto T, Seiki M. Integrated functions of membrane-type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase. Cancer Sci. 6: 1095-1100, 2017.
(88) Hara T, Nakaoka HJ, Hayashi T, Mimura K, Hoshino D, Inoue M, Nagamura
F, Murakami Y, Seiki M, Sakamoto T. Control of metastatic niche formation
by targeting APBA3/Mint3 in inflammatory monocytes. Proc Natl Acad Sci USA. 22: E4416-E4424, 2017.
(87) Fujiki K, Yano S, Ito T, Kumagai Y, Murakami Y, Kamigaito O, Haba
H, Tanaka K. A one-pot three-component double-click method for synthesis
of [67Cu]-labeled biomolecular radiotherapeutics. Sci Rep. 7: 1912, 2017.
(86) Nakaoka HJ, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato
H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M,
Murakami Y, Sakamoto T. Mint3-mediated L1CAM expression in fibroblasts
promotes cancer cell proliferation via integrin a5b1 and tumour growth.
Oncogenesis. 6: e334, 2017.
(85) Shirakabe K, Omura T, Shibagaki Y, Mihara E, Homma K, Kato Y, Yoshimura
A, Murakami Y, Takagi J, Hattori S, Ogawa Y. Mechanistic insights into
ectodomain shedding: susceptibility of CADM1 adhesion molecule is determined by alternative splicing and O-glycosylation. Sci Rep. 7: 46174, 2017.
(84) Uematsu T, Fujita T, Nakaoka HJ, Hara T, Kobayashi N, Murakami Y,
Seiki M, Sakamoto T. Mint3/Apba3 depletion ameliorates severe murine influenza
pneumonia and macrophage cytokine production in response to the influenza
virus. Sci Rep. 6: 37815, 2016.
(83) Awano M, Fujiyuki T, Shoji K, Amagai Y, Murakami Y, Furukawa Y, Sato H, Yoneda M, Kai C. Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells. Cancer Sci. 107: 1647-1652, 2016.
(82) Thang PM, Takano A, Yoshitake Y, Shinohara M, Murakami Y, Daigo Y.
Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic
target for oral cancer. Int J Oncol. 49: 1385-1393, 2016.
(81) Ito T, Matsubara D, Tanaka I, Makiya K, Tanei Z, Kumagai Y, Shiu SJ,
Nakaoka HJ, Ishikawa S, Isagawa T, Morikawa T, Ushiku A, Goto Y, Nakano
T, Tsuchiya T, Tsubochi H, Aburatani H, Dobashi Y, Nakajima J, Endo S,
Fukayama M, Sekido Y, Niki T, Murakami Y. Loss of YAP1 defines neuroendocrine
differentiation of lung tumor. Cancer Sci. 107: 1527-1538, 2016.
(80) Yoshino S, Hara T, Nakaoka HJ, Kanamori A, Murakami Y, Seiki M, Sakamoto
T. The ERK-signaling target RNF126 regulates anoikis resistance in cancer
cells by changing the mitochondrial metabolic flux. Cell Discov. 2: 16019, 2016.
(79) Nakaoka HJ, Hara T, Yoshino S, Kanamori A, Matsui Y, Shimamura T,
Sato H, Murakami Y, Seiki M, Sakamoto T. NECAB3 Promotes Activation of
Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity
of Cancer Cells. Sci Rep. 6: 22784, 2016.
(78) Dokduang H, Yongvanit P, Namwat N, Pairojkul C, Sangkhamanon S, Sakurai-Yageta
M, Murakami Y, Loilome W. Xanthohumol inhibits STAT3 activation pathway
leading to growth suppression and apoptosis induction in human cholangiocarcinoma
cells. Oncol Rep. 35: 2065-2072, 2016.
(77) Takeuchi A, Badr Mel S, Miyauchi K, Ishihara C, Onishi R, Guo Z, Sasaki
Y, Ike H, Takumi A, Tsuji NM, Murakami Y, Katakai T, Kubo M, Saito T. CRTAM
determines the CD4+ cytotoxic T lymphocyte lineage. J Exp Med. 213: 123-138, 2016
2013 - 2015
(76) Fujiyuki T, Yoneda M, Amagai Y, Obayashi K, Ikeda F, Shoji K, Murakami
Y, Sato H, Kai C. A measles virus selectively blind to signaling lymphocytic
activation molecule shows anti-tumor activity against lung cancer cells.
Oncotarget. 6: 24895-24903, 2015.
(75) Akashi K, Ebihara Y, Omura G, Saito Y, Yoshida M, Ando M, Asakage
T, Yamasoba T, Murakami Y. Frequent copy gain of the MET gene in hypopharyngeal
and laryngeal cancer in the Japanese population. J Cancer Therapy. 6: 1093-1102, 2015.
(74) Kogai H, Kikuchi S, Obana T, Tsuboi Y, Maruyama T, Sakurai-Yageta
M, Asamura H, Kanai Y, Murakami Y. Promoter methylation of the CADM1 and
4.1B genes occurs independently of the EGFR or the KRAS2 mutation in non-small
cell lung cancer. J Cancer Therapy. 6: 273-285, 2015.
(73) Sakurai-Yageta M, Maruyama T, Suzuki T, Ichikawa K, Murakami Y. Dynamic
regulation of a cell adhesion protein complex including CADM1 by combinatorial
analysis of FRAP with exponential curve-fitting. PLos One. 10: e0116637, 2015.
(72) Matsubara D, Kishaba Y, Yoshimoto T, Sakuma Y, Sakatani T, Tamura
T, Endo S, Sugiyama Y, Murakami Y, Niki T. Immunohistochemical analysis
of the expression of E-cadherin and ZEB1 in non-small cell lung cancer.
Pathol Int. 64: 560-568, 2014.
(71) Mimae T, Ito A, Hagiyama M, Nakanishi J, Hosokawa Y, Okada M, Murakami Y, Kondo T. A novel approach to pseudopodia proteomics: excimer laser etching, two-dimensional difference gel electrophoresis, and confocal imaging. Protoc exch. 2014.007.
(70) Dokduang H, Techasen A, Namwat N, Khuntikeo N, Pairojkul C, Murakami
Y, Loilome W, Yongvanit P. STATs profiling reveals predominantly-activated
STAT3 in cholangiocarcinoma genesis and progression. J Hepatobiliary Pancreat Sci. 21: 767-776, 2014.
(69) Ibrahim R, Matsubara D, Osman W, Morikawa T, Goto A, Morita S, Ishikawa
S, Aburatani H, Takai D, Nakajima J, Fukayama M, Niki T, Murakami Y. Expression
of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal
transition. Hum Pathol. 45: 1397-1405, 2014.
(68) Wang F, Akashi K, Murakami Y, Inoue Y, Furuta T, Yamada H, Ohmoto
K, Kiryu S. Detection of lung tumors in mice using a 1-tesla compact magnetic
resonance imaging system. PLoS One. 9: e94945, 2014.
(67) Cortez VS, Cervantes-Barragan L, Song C, Glifillan S, McDonald KG,
Tussiwand R, Edelson BT, Murakami Y, Murphy KM, Newberry RD, Sibley LD,
Colonna M. CRTAM controls residency of gut CD4+CD8+ T cells in the steady
state and maintenance of gut CD4+ Th17 during parasitic infection. J Exp Med. 211: 623-633, 2014.
(66) Ito T, Sakurai-Yageta M, Goto A, Pairojkul C, Yongvanit P, Murakami
Y. Genomic and transcriptional alterations of cholangiocarcinoma. J Hepatobiliary Pancreat Sci, 21: 380-387, 2014.
(65) Murakami S, Sakurai-Yageta M, Maruyama T, Murakami Y. Trans-homophilic
interaction of CADM1 activates PI3K by forming a complex with MAGuK-family
proteins MPP3 and Dlg. PLoS One, 9: e82894, 2014.
(64) Mimae T, Hagiyama M, Inoue T, Yoneshige A, Kato T, Okada M, Murakami
Y, Ito A. Increased ectodomain shedding of lung epithelial cell adhesion
molecule 1 as a cause of increased alveolar cell apoptosis in emphysema.
Thorax, 69: 223-231, 2013.
(63) Matsubara D, Kishaba Y, Ishikawa S, Sakatani T, Oguni S, Tamura T,
Hoshino H, Sugiyama Y, Endo S, Murakami Y, Aburatani H, Fukayama M and
Niki T. Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal
transition phenotype and distinct histologic and genetic features. Cancer Sci, 104: 266-273, 2013.
2010 - 2012
(62) Matsubara D, Kanai Y, Ishikawa S, Ohara S, Yoshimoto T, Sakatani T,
Oguni S, Tamura T, Kataoka H, Endo S, Murakami Y, Aburatani H, Fukayama
M. and *Niki T. Identification of CCDC6-RET fusion in the human lung adenocarcinoma
cell line, LC-2/ad. J Thorac Oncol, 7: 1872-1876, 2012.
(61) Ishimura M, Sakurai-Yageta M, Maruyama T, Ando T, Fukayama M, Goto
A, Murakami Y. Involvement of miR-214 and miR-375 in malign.ant features
of non-small-cell lung cancer by down-regulating CADM1. J Cancer Therapy, 3:379-387, 2012.
(60) Ito A, Mimae T, Yamamoto Y-S-Z, Hagiyama M, Nakanishi J, Ito M, Hosokawa
Y, Okada M, Murakami Y, and Kondo T. Novel application for pseudopodia
proteomics using excimer laser ablation and two-dimensional difference
gel electrophoresis. Lab Invest, 92:1374-1385, 2012.
(59) Nakata H, Wakayama T, Adthapanyawanich K, Nishiuchi T, Murakami Y, Takai Y, Iseki S. Compensatory upregulation of myelin protein zero-like 2 expression in spermatogenic cells in cell adhesion molecule-1-deficient mice. Acta Histochem Cytochem, 45:47-56. 2012.
(58) Kikuchi S, Iwai M, Sakurai-Yageta M, Tsuboi Y, Ito T, Masuda T, Tsuda
H, Kanai Y, Onizuka M, Sato Y, and Murakami Y. Expression of a splicing
variant of the CADM1 specific to small cell lung cancer. Cancer Science, 103, 1051-1057, 2012.
(57) Ito A, Ichiyanagi N, Ikeda Y, Hagiyama M, Inoue T, Kimura KB, Sakurai MA, Hamaguchi K, Murakami Y. Adhesion molecule CADM1 contributes to gap junctional communication among pancreatic islet α-cells and prevents their excessive secretion of glucagon. Islets, in press.
(56) Mimae T, Okada M, Hagiyama M, Miyata Y, Tsutani Y, Inoue T, Murakami
Y, Ito A. Notch2 and Six1 are up-regulated during progression of early-stage
lung adenocarcinoma and define its unfavorable subset at advanced stages.
Clinical Cancer Research, 18, 945-948, 2012.
(55) Nagara Y, Hagiyama M, Hatano, N, Futai, E, Suo S, Takaoka Y, Murakami
Y, Ishiura S, and Ito A. Tumor suppressor cell adhesion molecule 1 (CADM1)
is cleaved by A disintegrin and metalloprotease 10 (ADAM10) and subsequently
cleaved by gamma-secretase complex. Biochem Biophys Res Commun, 417:462-467, 2012.
(54) Ito T, Williams-Nate Y, Iwai M, Tsuboi Y, Hagiyama M, Ito A, Sakurai-Yageta
M, Murakami Y. Transcriptional regulation of the CADM1 gene by retinoic
acid during the neural differentiation of murine embryonal carcinoma P19
cells. Genes to Cells, 16:791-802, 2011.
(53) Nagata M, Sakurai-Yageta M, Yamada D,Goto A, Ito A, Fukuhara H, Kume
H, Morikawa T, Fukayama M, Homma Y, Murakami Y. Aberrations of a cell adhesion
molecule CADM4 in renal clear cell carcinoma. Int J Cancer, 130:1329-1337, 2011.
(52) Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, Sakurai-Yageta M,
Ito A, Goto A, Saito M, Kasumi F, Murakami Y. Aberrant expression of tumor
suppressors, CADM1 and 4.1B, in invasive lesions of primary breast cancer.
Breast Cancer, 19:242-252, 2011.
(51
) Hagiyama M, Furuno T, Hosokawa Y, Iino T, Ito T, Inoue T, Nakanishi M, Murakami Y, Ito A.
Enhanced nerve-mast cell interaction by a neuronal short isoform of cell adhesion molecule-1.
J Immunol, 186(10), 5983-92, 2011.
(50) Mimae T, Tsuta K, Takahashi F, Yoshida A, Kondo T, Murakami Y, Okada M, Takeuchi M, Asamura H, Tsuda H. Steroid Receptor Expression in Thymomas and Thymic Carcinomas. Cancer, 117: 4396-4405, 2011.
(49) Hosokawa Y, Hagiyama M, Iino T, Murakami Y, Ito A. Noncontact estimation of intercellular breaking force using a femtosecond laser impulse quantified by atomic force microscopy.
Proc Natl Acad Sci U S A, 108(5), 1777-82, 2011.
(48) Masuda M, Maruyama T, Ohta T, Ito A, Hayashi T, Tsukasaki K, Kamihira S, Yamaoka S, Hoshino H, Yoshida T, Watanabe T, Stanbridge EJ, Murakami Y. CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells.
J Biol Chem, 285(20), 15511-22, 2010.
2007 - 2009
(47) Sakurai-Yageta M, Masuda M, Tsuboi Y, Ito A, Murakami Y. Tumor suppressor CADM1 is involved in epithelial cell structure.
Biochem Biophys Res Commun, 390(3), 977-82, 2009.
(46) Hagiyama M, Ichiyanagi N, Kimura KB, Murakami Y, Ito A. Expression of a soluble isoform of cell adhesion molecule 1 in the brain and its involvement in directional neurite outgrowth.
Am J Pathol, 174(6), 2278-89, 2009.
(45) Overmeer RM, Henken FE, Snijders PJ, Claassen-Kramer D, Berkhof J, Helmerhorst TJ, Heideman DA, Wilting SM, Murakami Y, Ito A, Meijer CJ, Steenbergen RD. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
J Pathol, 215(4), 388-97, 2008.
(44) Wakayama T, Sai Y, Ito A, Kato Y, Kurobo M, Murakami Y, Nakashima
E, Tsuji A, Kitamura Y, Iseki S. Heterophilic binding of the adhesion molecules
poliovirus receptor and immunoglobulin superfamily 4A in the interaction
between mouse spermatogenic and Sertoli cells. Biology Reprod, 76, 1081-1090, 2007.
(43) Kawasaki A, Tsuchiya N, Ohashi J, Murakami Y, Fukazawa T, Kusaoi M, Morimoto S, Matsuda K, Hashimoto H, Takasaki Y, Tokunaga K. Role of APRIL (TNSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese. Rheumatology, 46, 776-782, 2007..
(42) Ito, A, Hagiyama, M, Oonuma, J, Murakami, Y, Yokozaki, H, Takaki,
M. Involvement of the SgIGSF/Necl-2 adhesion molecule in degradation of
mesenteric mast cells. J Neuro Immunol, 184, 209-213, 2007.
2004 - 2006
(41) Lung, HL, Kwok, A, Cheung, L, Xie, D, Cheng, Y, Murakami, M, Guan,
X-Y, Sham, JS, Chua, D, Protopopov, AI, Zabarovsky, ER, Tsao, SW, Stanbridge,
EJ, and Lung, ML. TSLC1 is a tumor suppressor gene associated with metastasis
in nasopharyngeal carcinoma. Cancer Res, 66, 9385-9392, 2006.
(40) Yamada, D, Yoshida, M, Williams, YN, Fukami, T, Kikuchi, S, Masuda,
Maruyama, M, Ohta, T, Nakae, D, Maekawa, A, Kitamura, T, Murakami, Y. Disruption
of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4,
an immunoglobulin superfamily cell adhesion molecule. Mol Cell Biol, 26, 3610-3624, 2006.
(39) Weyden, LVD, Arends, MJ, Chausiaux, OE, Lange, UC, Surani, MA, Affara,
N, Murakami, Y, Adams, DJ, Bradley. A. Loss of TSLC1 causes male infertility
due to a defect at the spermatid stage of spermatogenesis, Mol Cell Biol, 26, 3595-3609, 2006.
(38) Kikuchi, S, Yamada, D, Fukami, T, Maruyama, T, Ito, A, Asamura, H,
Matsuno, Y, Onizuka, M, Murakami, Y. Hypermethylation of the TSLC1/IGSF4
promoter is associated with tobacco smoking and a poor prognosis in primary
non-small cell lung cancer. Cancer, 106, 1751-1758, 2006.
(37) Williams, YN, Masuda, M, Sakurai-Yageta, M, Maruyama, T, Shibuya,
M, Murakami, Y. Cell adhesion and prostate tumor suppressor activity of
TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4. Oncogene, 25, 1446-1453, 2006.
(36) Yamada, D, Kikuchi, S, Williams, YN, Sakurai-Yageta, M, Masuda, M, Maruyama, T, Tomita, K, Gutmann, DH, Kakizoe, T, Kitamura, T, Murakami, Y. Promoter Hypermethylation of the Potential Tumor Suppressor DAL-1/4.1B Gene in Renal Clear Cell Carcinoma. Int J Cancer, 118, 916-923, 2006.
(35) Masuda, M, Kikuchi, S, Maruyama, T, Sakurai-Yageta, M, Williams, YN,
Ghosh HP, Murakami, Y. TSLC(tumor suppressor in lung cancer)1 suppresses
epithelial cell scattering and tubulogenesis. J Biol. Chem, 280, 42164-42171, 2005.
(34) Sussan, TE, Pletcher, MT, Murakami, Y, Reever, RH. Tumor suppressor
in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene
expression. Mol. Cancer, 4, 28, 2005.
(33) Kuroki, K, Tsuchiya, N, Shiroishi, M, Rasubala, L, Yamashita, Y, Matsuta,
K, Fukuzawa, T, Kusaoi, M, Murakami, Y, Takiguchi, M, Juji, T, Hashimoto,
H, Kohda, D, Maenaka, K, Tokunaga, K. Extensive polymorphisms of LILRB1
(ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative
rheumatoid arthritis. Hum Mol Genet, 14, 2469-2480, 2005.
(32) Murakami, Y. Involvement of a cell adhesion molecule, TSLC1/IGSF4,
in human oncogenesis. Cancer Sci., 96, 543-552, 2005.
(31) Goto, A, Niki, T, Chi-pin, L, Matsubara, D, Murakami, Y, Funata, N,
Fukayama, M. Loss of TSLC expression in lung adencarcinoma: relationships
with histological subtypes, gender, and prognostic significance. Cancer Sci, 96, 480-486, 2005.
(30) Kikuchi, S, Yamada, D, Fukami, T, Masuda, M, Sakurai-Yageta, M, Williams, YN, Maruyama, T, Asamura, H, Matsuno, Y, Onizuka, M, Murakami, Y. Promoter methylation of the DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Clin. Cancer Res., 11, 2954-2961, 2005.
(29) Mototani, H, Mabuchi, A, Saito, S, Fujioka, M, Iida, A, Takatori,
Y, Kotani, A, Kubo, T, Nakamura, K, Sekine, A, Murakami, Y, Tsunoda, T,
Notoya, K, Nakamura, Y, Ikegawa, S. A functional single nucleotide polymorphism
in the core promoter region of CALM1 is associated with hip osteoarthritis
in Japanese. Hum Mol. Genet., 14, 1009-1017, 2005.
(28) Sasaki, H, Nishikata, I, Shiraga, T, Akamatsu, E, Ishida, Y, Fukami,
T, Hidaka, T, Kubuki, Y, Okayama, A, Hamada, K, Okabe, H, Murakami, Y,
Tsubouchi, H, Morishita, K. Overexpression of a cell adhesion molecule,
TSLC1, as a possible molecular marker for acute type of adult T-cell leukemia.
Blood, 105:1204-1213, 2005.
(27) Tsuchiya, N., Kuroki, K., Fujimoto, M., Murakami, Y., Tedder, T.F., Tokunaga, K., Takehara, K., Sato, S. Association of functional CD19 polymorphism with susceptibility to systemic sclerosis (scleroderma). Arthritis Rheum., 50:4002-4007, 2004.
(26) Murakami, Y., Isogai, K., Tomita, H., Sakurai-Yageta, M., Maruyama,
T., Hidaka, A., Nose, K., Sugano, K., Kaneko A. Detection of allelic imbalance
in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of
hereditary non-polyposis colorectal cancer and retinoblastoma by an RNA
difference plot. J. Hum. Genet., 49:635-641, 2004.
(25) Surace, E.I., Murakami, Y., Scheithauer, B.W., Perry, A., Gutmann,
D.H. Tumor suppressor in lung cancer-1 (TSLC1) expression is lost in sporadic
meningioma. J. Neuropathol. Exp. Neurol., 63:1015-1027, 2004.
(24) Lung, H.L., Cheng, Y., Kumaran, M.K., Liu, E.T.-B., Murakami, Y.,
Chan, C.Y., Yau, W.L., Stanbridge, E.J., Lung, M.L. Fine mapping of 11q22-23
tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma.
Int. J. Cancer, 112:628-635, 2004.
(23) Saino, M., Maruyama, T., Sekiya, T., Kayama, T., Murakami, Y. Inhibition
of angiogenesis in human glioma cell lines by antisense RNA from the soluble
guanylate cyclase genes, GUCY1A3 and GUCY1B3. Oncol. Rep., 12:47-52, 2004.
(22) Sugano, K., Yoshida, T., Izumi, H., Umezawa S., Ushiama M., Ichikawa, A., Hidaka, A., Murakami, Y., Kodama, T., Suzuki, S., Kaneko, A. Outpatient clinic for genetic counseling and gene testing of retinoblastoma. Int. J. Clin. Oncol., 9:25-30, 2004.
2001 - 2003
(21) Fukami, T., Satoh, H., Williams, YN., Masuda, M., Fukuhara, H., Maruyama,
T., Yageta, M., Kuramochi, M., Takamoto, S., Murakami, Y. Isolation of
the mouse Tsll1 and Tsll2 genes, orthologues of the human TSLC1-like genes
1 and 2 (TSLL1 and TSLL2). Gene, 323:11-18, 2003.
(20) Mao, X., Seidlitz, E., Ghosh, K., Murakami, Y., Ghosh, H.P. The cytoplasmic
domain is critical to the tumour suppressor activity of TSLC1 in non-small
cell lung cancer. Cancer Res., 63:7979-7985, 2003.
(19) Ito, T., Shimada, Y., Hashimoto, Y., Kaganoi, J., Kan, T., Watanabe,
G., Murakami, Y., Imamura, M. Involvement of TSLC1 in progression of esophageal
squamous cell carcinoma. Cancer Res., 63:6320-6326, 2003.
(18) Fukuhara, H., Masuda, M., Yageta, M., Fukami, T., Kuramochi, M., Maruyama,
T., Kitamura, T., Murakami, Y. Association of a lung tumor suppressor TSLC1
with MPP3, a human homologue of drosophila tumor suppressor Dlg. Oncogene, 22:6160-6165, 2003.
(17) Fukami, F., Fukuhara, H., Kuramochi, M., Maruyama, T., Isogai, K.,
Sakamoto, M., Takamoto, S., Murakami, Y. Promoter methylation of the TSLC1
gene in advanced lung tumors and various cancer cell lines. Int. J. Cancer, 107:53-59, 2003.
(16) Murakami, Y. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene, 21:6936-6948, 2002.
(15) Yageta, M., Kuramochi, M., Masuda, M., Fukami, T., Fukuhara, H., Maruyama,
T., Shibuya, T., Murakami, Y. Direct association of TSLC1 and DAL-1, two
distinct tumor suppressor proteins in lung cancer. Cancer Res., 62:5129-5133, 2002.
(14) Fukami, F., Fukuhara, H., Kuramochi, 53) Fukami, T., Satoh, H., Maruyama,
T., Fukuhara, H., Kuramochi, M., Takamoto, S., Momoi, T., Murakami, Y.
Identification of the Tslc1 gene, a mouse orthologue of the human tumor
suppressor TSLC1 gene. Gene, 295:7-12, 2002.
(13) Masuda, M., Yageta, M., Fukuhara, H., Kuramochi, M., Maruyama, T.,
Nomoto, A., Murakami, Y. The tumor suppressor protein TSLC1 is involved
in cell-cell adhesion. J Biol. Chem., 277:31014-31019, 2002.
(12) Honda, T., Tamura, G., Waki, T., Jin, Z., Sato, K., Motoyama, T., Kawata, S., Kimura, W., Nishizuka, S., Murakami, Y. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn. J. Cancer Res., 93:857-860, 2002.
(11) Fukuhara, H., Kuramochi, M., Fukami, T., Kasahara, K., Furuhata, M.,
Nobukuni, T., Maruyama, T., Isogai, K., Sekiya, T., Shuin, T., Kitamura,
T., Reeves, R.H., Murakami, Y. Promoter methylation of the TSLC1 and tumor
suppression by its gene product in human prostate cancer. Jpn. J. Cancer Res., 93:605-609, 2002.
(10) Tamura, K., Miwa, W., Maruyama, T., Sekiya, T., Murakami, Y. Homozygous
deletion on the chromosomal region 5q12.3 in human lines of small-cell
lung cancers. J Hum. Genet., 47:348-354, 2002.
(9) Fukuhara, H., Kuramochi. M., Nobukuni, T., Fukami, T., Saino, M., Maruyama,
T., Nomura, N., Sekiya, T., Murakami, Y. Isolation of the TSLL1 and TSLL2
genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane
proteins. Oncogene, 20:5401-5407, 2001.
(8) Pletcher, M.T., Nobukuni, T., Fukuhara, H., Kuramochi, M., Maruyama, T., Sekiya, T., Sussan, T., Isomura, M., Murakami, Y., Reeves, R.H. Identification of tumor suppressor candidate genes by physical and sequence mapping of the TSLC1 region of human chromosome 11q23. Gene, 273:181-189, 2001.
(7) Kuramochi, M., Fukuhara, H., Nobukuni, T., Kanbe, T., Maruyama, T.,
Ghosh, H.P., Pletcher, M., Isomura, M., Onizuka, M., Kitamura, T., Sekiya,
T., Reeves, R.H., Murakami, Y. TSLC1 is a tumor suppressor gene in human
non-small cell lung cancer. Nat. Genet., 27:427-430, 2001.
(6) Kanbe, T., Nobukuni, T., Kawasaki, H., Sekiya, T., Murakami, Y. Four
single-nucleotide polymorphisms in the human BUB1 gene. J Hum. Genet., 46:150-151, 2001.
(5) Nishimoto, A., Miura, N., Horikawa, I., Kugoh, H., Murakami, Y., Hirohashi,
S., Kawasaki, H., Barrett, C.J., Gazdar, A.F., Shay, J.W., Oshimura, M.
Evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene, 20:828-835, 2001
- 2000 (representative publications)
(4) Murakami, Y., Uejima, H., Fukuhara, H., Maruyama, T., Oshimura, M., Sekiya, T. Construction of human-rodent hybrids containing fragments of human chromsome 10p. J Hum. Genet., 45:370-373, 2000.
(3) Kanamori, M., Kon, H., Nobukuni, T., Nomura, S., Sugano, K., Mashiyama,
S., Kumabe, T., Yoshimoto, T., Meuth, M., Sekiya, T., Murakami, Y. Microsatellite
instability and the PTEN1 gene mutation in a subset of early onset gliomas
carrying germline mutation or promoter methylation of the hMLH1 gene. Oncogene, 19:1564-1571, 2000.
(2) Kuchiki, H., Saino, M., Nobukuni, T, Yasuda, J., Maruyama, T., Kayama,
Y, Murakami, Y., Sekiya, T. Detection of amplification of a chromosomal
fragment at 6p21 including the Cyclin D3 gene in a glioblastoma cell line
by arbitrarily primed polymerase chain reaction. Int. J Cancer, 85:113-116, 2000.
(1) Murakami, Y., Nobukuni, T., Tamura, K., Maruyama, T., Sekiya, T., Arai,
Y., Gomyou, H., Tanigami, A., Ohki, M., Cabin, D., Frischmyer, P., Hunt,
P., Reeves, R.H. Localization of tumor suppressor activity important in
non-small cell lung carcinoma on chromosome 11q. Proc. Natl. Acad. Sci. USA, 95:8153-8158, 1998.
